Self-Guided Personalized Treatment for Women

Personalizing Disordered Eating Treatment Using Mobile Technology: Self-Guided, Personalized Treatment for Women

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05920720

Enrollment

Registered

2023-06-27

Start date

2025-02-28

Completion date

2026-03-06

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disordered Eating

Keywords

Treatment, Therapy, Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Atypical Anorexia Nervosa, Other specified feeding and eating disorder

Brief summary

The investigators plan to collect preliminary data on the feasibility, acceptability, and user uptake of a personalized self-guided mobile intervention for disordered eating (DE) and test the initial clinical efficacy of this intervention. Women (N=50) who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones. The investigators will assess engagement with the modules throughout two months and administer baseline, week 5, and week 8 assessments for acceptability, uptake, and initial clinical efficacy (e.g., DE symptoms, anxiety, quality of life). The investigators will also complete a focus group (n=10) with a subset of users to receive input on the mobile-application assessment and ease of self-guided intervention modules.

Interventions

BEHAVIORALSelf-guided Personalized Treatment

Women who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Endorse disordered eating (score of 2.3 or above on EDE-Q6) * Age 18-65 * Ability to read and write English * Own a smartphone or tablet

Exclusion criteria

* Active mania * Active suicidality * Active psychosis

Design outcomes

Primary

Measure	Time frame	Description
Disordered eating symptoms	Up to 8 weeks	Changes in disordered eating symptoms will be assessed with the Eating Disorder Examination Questionnaire-6 (EDE-Q6)
Anxiety	Up to 8 weeks	Changes in anxiety will be assessed with the Penn State Worry Questionnaire (PSWQ)
Depression	Up to 8 weeks	Changes in depression will be assessed with the Beck Depression Inventory-2 (BDI-2)
Clinical Impairment	Up to 8 weeks	Changes in clinical impairment will be assessed with the Clinical Impairment Assessment (CIA)

Secondary

Measure	Time frame	Description
Quality of life	Up to 8 weeks	Changes in quality of life will be assessed with the Quality of Life Scale (QOLS)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCheri A Levinson

University of Louisville

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026